← Open Payments lookup

ANITA FAZZIO: Open Payments

NPI 1215651476 · RACELAND, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$590 in 20 payments from 12 companies in 2025. Trend: 2023 $229 · 2024 $478 · 2025 $590

Food & beverage: $590
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)4$148
ABBVIE INC.3$101
Neurocrine BioSciences, Inc.1$65
Vanda Pharmaceuticals Inc.3$58
Otsuka America Pharmaceutical, Inc.2$58
UCB, Inc.1$32
Axsome Therapeutics, Inc.1$29
Corcept Therapeutics1$25
Janssen Pharmaceuticals, Inc1$24
Eisai Inc.1$19

Products named: CAPLYTA, VRAYLAR, INGREZZA, FANAPT, REXULTI, Fintepla, Auvelity, Korlym.

Industry payments across LA — which companies pay providers there.